Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of CIN2+ Rates up to 120 Months After 48-Month Co-Testing (Long Term Follow up of HPV FOCAL Participants)

NCT04185389 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04185389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of CIN2+ Rates up to 120 Months After 48-Month Co-Testing (Long Term Follow up of HPV FOCAL Participants)
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
September 30, 2020
Completion date
December 31, 2024
Enrollment
1,710 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer